{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:48:05Z","timestamp":1762231685678,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005788","name":"Medizinische Universit\u00e4t Wien","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005788","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["50539-2025"],"award-info":[{"award-number":["50539-2025"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008003","name":"Korea Institute of Radiological & Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.dmd.2025.100091","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T02:20:36Z","timestamp":1746757236000},"page":"100091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of dose linearity in the systemic availability and pharmacokinetics of topically administered diclofenac: A 14C-microdosing study in healthy volunteers"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5094-9351","authenticated-orcid":false,"given":"Severin","family":"Mairinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5860-7989","authenticated-orcid":false,"given":"Mihye","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4818-1560","authenticated-orcid":false,"given":"Martin","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinho","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Lackner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anselm","family":"Jorda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2679-8589","authenticated-orcid":false,"given":"Iris K.","family":"Minichmayr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ka Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4126-956X","authenticated-orcid":false,"given":"Min Sun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8712-2092","authenticated-orcid":false,"given":"Jae Hoon","family":"Shim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R.","family":"Dueker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Zeitlinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4048-5781","authenticated-orcid":false,"given":"Oliver","family":"Langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmd.2025.100091_bib1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1025719827072","article-title":"Serum protein binding of nonsteroidal antiinflammatory drugs: a comparative study","volume":"25","author":"Borg\u00e5","year":"1997","journal-title":"J Pharmacokinet Biopharm"},{"key":"10.1016\/j.dmd.2025.100091_bib2","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2125.2011.03914.x","article-title":"A new topical formulation enhances relative diclofenac bioavailability in healthy male subjects","volume":"71","author":"Brunner","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmd.2025.100091_bib3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2125.2005.02484.x","article-title":"Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation","volume":"60","author":"Brunner","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmd.2025.100091_bib4","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.yrtph.2009.04.002","article-title":"Relative absorption and dermal loading of chemical substances: consequences for risk assessment","volume":"54","author":"Buist","year":"2009","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.dmd.2025.100091_bib5","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/cts.13269","article-title":"Strategic, feasibility, economic, and cultural aspects of phase 0 approaches: is it time to change the drug development process in order to increase productivity?","volume":"15","author":"Burt","year":"2022","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.dmd.2025.100091_bib6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41573-020-0080-x","article-title":"Phase 0\/microdosing approaches: time for mainstream application in drug development?","volume":"19","author":"Burt","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.dmd.2025.100091_bib7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1365-2125.2011.04128.x","article-title":"Convective transport of highly plasma protein bound drugs facilitates direct penetration into deep tissues after topical application","volume":"73","author":"Dancik","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.dmd.2025.100091_bib8","unstructured":"European Medicines Agency (2024) Guideline on quality and equivalence of locally applied, locally acting cutaneous products. EMA\/CHMP\/QWP\/708282\/2018 Corr.1\u2217. 9 September 2024."},{"key":"10.1016\/j.dmd.2025.100091_bib9","unstructured":"Food and Drug Administration (2019) Maximal usage trials for topically applied active ingredients being considered for inclusion in an over-the-counter monograph: study elements and considerations guidance for industry."},{"key":"10.1016\/j.dmd.2025.100091_bib10","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1021\/ac971383v","article-title":"Analytical performance of accelerator mass spectrometry and liquid scintillation counting for detection of 14C-labeled atrazine metabolites in human urine","volume":"70","author":"Gilman","year":"1998","journal-title":"Anal Chem"},{"key":"10.1016\/j.dmd.2025.100091_bib11","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ijpharm.2014.07.052","article-title":"Formulation of diclofenac for dermal delivery","volume":"473","author":"Goh","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.dmd.2025.100091_bib12","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1208\/s12248-017-0108-2","article-title":"Microdialysis as an important technique in systems pharmacology-a historical and methodological review","volume":"19","author":"Hammarlund-Udenaes","year":"2017","journal-title":"AAPS J"},{"key":"10.1016\/j.dmd.2025.100091_bib13","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jconrel.2012.10.011","article-title":"ATP binding cassette transporters in two distinct compartments of the skin contribute to transdermal absorption of a typical substrate","volume":"165","author":"Hashimoto","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.dmd.2025.100091_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000314698","article-title":"Microdialysis sampling for investigations of bioavailability and bioequivalence of topically administered drugs: current state and future perspectives","volume":"23","author":"Holmgaard","year":"2010","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.dmd.2025.100091_bib15","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1023\/A:1011911302005","article-title":"In vivo bioavailability and metabolism of topical diclofenac lotion in human volunteers","volume":"15","author":"Hui","year":"1998","journal-title":"Pharm Res"},{"key":"10.1016\/j.dmd.2025.100091_bib16","unstructured":"ICH Expert Working Group (2009) Guidance on nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals M3(R2)."},{"key":"10.1016\/j.dmd.2025.100091_bib17","first-page":"1","article-title":"ICRP Publication 62","volume":"22","year":"1992","journal-title":"Ann ICRP"},{"key":"10.1016\/j.dmd.2025.100091_bib18","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/2160763X11430162","article-title":"A novel study using accelerated mass spectrometry to evaluate the pharmacokinetics of total 14C AL-8309 (tandospirone) following topical ocular administration in heealthy male subjects","volume":"1","author":"Iyer","year":"2012","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.dmd.2025.100091_bib19","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/bcpt.13709","article-title":"Diclofenac in vitro microdialysis study comparing different experimental set-ups to improve quantitative recovery","volume":"130","author":"Jorda","year":"2022","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.dmd.2025.100091_bib20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4155\/bio.10.14","article-title":"Analytical validation of accelerator mass spectrometry for pharmaceutical development","volume":"2","author":"Keck","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmd.2025.100091_bib21","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/jes.2010.22","article-title":"The mismeasure of dermal absorption","volume":"21","author":"Kissel","year":"2011","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"10.1016\/j.dmd.2025.100091_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1124\/dmd.108.023200","article-title":"Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and benzbromarone","volume":"37","author":"Lagas","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmd.2025.100091_bib23","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4155\/bio-2022-0064","article-title":"Accelerator mass spectrometry for quantification of micro- and therapeutic-dose diclofenac in microdialysis samples","volume":"14","author":"Langer","year":"2022","journal-title":"Bioanalysis"},{"key":"10.1016\/j.dmd.2025.100091_bib24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clpt.2006.05.008","article-title":"Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs","volume":"80","author":"Lappin","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100091_bib25","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejps.2011.04.009","article-title":"Comparative pharmacokinetics between a microdose and therapeutic dose for clarithromycin, sumatriptan, propafenone, paracetamol (acetaminophen), and phenobarbital in human volunteers","volume":"43","author":"Lappin","year":"2011","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.dmd.2025.100091_bib26","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/bmj.324.7337.588","article-title":"Science, medicine, and the future: microdialysis","volume":"324","author":"M\u00fcller","year":"2002","journal-title":"Br Med J"},{"key":"10.1016\/j.dmd.2025.100091_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0009-9236(97)90032-1","article-title":"Diclofenac concentrations in defined tissue layers after topical administration","volume":"62","author":"M\u00fcller","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dmd.2025.100091_bib28","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1021\/ac026334j","article-title":"A high-throughput method for the conversion of CO2 obtained from biochemical samples to graphite in septa-sealed vials for quantification of 14C via accelerator mass spectrometry","volume":"75","author":"Ognibene","year":"2003","journal-title":"Anal Chem"},{"key":"10.1016\/j.dmd.2025.100091_bib29","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s40262-021-01091-1","article-title":"Microdosing as a potential tool to enhance clinical development of novel antibiotics: a tissue and plasma PK feasibility study with ciprofloxacin","volume":"61","author":"Oesterreicher","year":"2022","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dmd.2025.100091_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2005.01.017","article-title":"Microdialysis--theoretical background and recent implementation in applied life-sciences","volume":"25","author":"Plock","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.dmd.2025.100091_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113929","article-title":"Topical drug delivery: history, percutaneous absorption, and product development","volume":"177","author":"Roberts","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.dmd.2025.100091_bib32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3109\/00498257909042328","article-title":"Biotransformation of diclofenac sodium (Voltaren) in animals and in man. II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile","volume":"9","author":"Stierlin","year":"1979","journal-title":"Xenobiotica"},{"key":"10.1016\/j.dmd.2025.100091_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF03190043","article-title":"Diclofenac metabolic profile following in vitro percutaneous absorption through viable human skin","volume":"24","author":"Tanojo","year":"1999","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.dmd.2025.100091_bib34","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s40262-019-00769-x","article-title":"Predictive value of microdose pharmacokinetics","volume":"58","author":"van Nuland","year":"2019","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dmd.2025.100091_bib35","series-title":"Mass Spectrometry in Drug Metabolism and Disposition: Basic Principles and Applications","first-page":"525","article-title":"Quantitative drug metabolism with accelerator mass spectrometry","author":"Vogel","year":"2011"},{"key":"10.1016\/j.dmd.2025.100091_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/11537250-000000000-00000","article-title":"A combined accelerator mass spectrometry-positron emission tomography human microdose study with 14C- and 11C-labelled verapamil","volume":"50","author":"Wagner","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.dmd.2025.100091_bib38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00003088-199223040-00002","article-title":"Percutaneous absorption of drugs","volume":"23","author":"Wester","year":"1992","journal-title":"Clin Pharmacokinet"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955625091007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:43:39Z","timestamp":1762231419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955625091007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0090955625091007"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100091","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of dose linearity in the systemic availability and pharmacokinetics of topically administered diclofenac: A 14C-microdosing study in healthy volunteers","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2025.100091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100091"}}